Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

NCT04014062 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers

Interventions

COMBINATION_PRODUCT: INTP5
COMBINATION_PRODUCT: US Neulasta

Sponsor

Intas Pharmaceuticals, Ltd.

Collaborators

[object Object]